NEW YORK (GenomeWeb News) – Bioinformatics firm BioDiscovery and the Autism Genetic Resource Exchange today announced a co-marketing agreement that allows AGRE to provide copy number and allelic event data to its researchers through BioDiscovery's Nexus DB platform.

BioDiscovery's platform is for DNA copy number analysis and integrates and processes data from commercial array platforms as well as custom arrays. AGRE, a program of Autism Speaks, collects and houses genetic and phenotypic data on more than 1,300 families with autism.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.